CI Earnings Prediction
The chart below shows how CI performed 10 days before and after its earnings report, based on data from the past quarters. Typically, CI sees a +0.20% change in stock price 10 days leading up to the earnings, and a -0.66% change 10 days following the report. On the earnings day itself, the stock moves by -0.47%. This data can give you a slight idea of what to expect for the next quarter's release.
CI Key Earning Data
2024/Q4
Year Over Year
Quarter Over Quarter
Total Revenue
65.65B
28.44%
3.07%
Gross Margin
9.20%
-23.21%
-4.96%
Operating Margin
3.46%
-30.38%
-17.03%
Net Margin
2.34%
7.83%
80.00%
EPS
5.13
46.99%
95.06%
No Data Available
CI Earnings Analysis
Cigna Group Corporation (CI.N) Earnings Conference Call
Positive
Strong Revenue Performance: Full year revenue growth of 27% to approximately $247 billion, indicating strong overall performance.
Earnings Per Share Growth: Full year adjusted earnings per share of $27.33, representing a 9% year-over-year increase, showcasing solid profitability.
Shareholder Value Commitment: Returned $8.6 billion to shareholders through dividends and share repurchases, reflecting a commitment to shareholder value.
Earnings Growth in Health Services: Earnings from Evernorth Health Services segment grew 14% to $2.1 billion, driven by strong performance in specialty and care services.
Dividend Increase Announcement: The Board of Directors declared an 8% increase in the quarterly dividend to $1.51 per share, demonstrating confidence in future cash flows.
Negative
Net After Tax Charges: Net after tax special item charges of $64 million or $0.23 per share were recorded, indicating a significant financial burden impacting overall earnings.
Rising Medical Costs Impact Earnings: Fourth quarter revenues of $13.3 billion resulted in pre-tax adjusted earnings of only $511 million, reflecting a medical care ratio of 87.9%, which is considerably higher than expected and indicates rising medical costs.
Medical Care Ratio Insights: The full year medical care ratio reached 83.2%, exceeding guidance and suggesting ongoing pressure from elevated medical costs, particularly in the stop loss product segment.
Medical Care Ratio Outlook: The company expects a slightly higher medical care ratio for stop loss in 2025, indicating continued margin pressure and a potential negative impact on profitability moving forward.
Customer Base Contraction: Despite a strong capital position, the divestiture of the Medicare business is expected to reduce total medical customers to approximately 18.1 million, reflecting a contraction in the customer base and potential revenue loss.
CI FAQs
How does CI typically perform around its earnings report dates?
Is Cigna Group (CI) Q4 2024 Earnings Call Summary positive or negative?
How can historical earnings data help predict future stock performance?
CI Earning Call Sentiment
Earnings call transcript: Cigna Q4 2024 misses EPS forecast, stock drops
CI.N
1.87%Positive
The earnings call shows mixed signals: strong revenue growth and shareholder returns are positive, but the adjusted EPS missed expectations, and the medical care ratio is above guidance, indicating cost pressures. Although management provided optimistic guidance for 2025, they were unclear about the impact of the Medicare divestiture and stop loss margin recovery. These uncertainties, combined with a lack of market cap data, suggest a neutral stock price movement over the next two weeks.
